+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-03-23Number of Pages: 109

Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing (DST) and Other TB Tests): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020


A considerable portion of the population across geographies are suffering from a wide range of infectious diseases such as influenza, tuberculosis, AIDS, and several other bacterial and viral diseases. Tuberculosis or TB is one of the leading causes of death worldwide. Currently, organizations such as the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) have contributed largely towards improving global awareness regarding TB, its diagnosis, and available treatment options through TB control programs such as Stop TB. According to the WHO, in 2013, there were around 9 million new TB cases and close to 1.5 million TB deaths worldwide.

The global tuberculosis testing market has been categorized into seven segments based on major TB test types - smear microscopy, culture based tests, nucleic acid testing, Mantoux test, radiography (chest x-ray), drug susceptibility testing, and other tests such as serological tests, Interferon-Gamma Release Assays (IGRA), phage based tests, antigen-based tests, antibody-based tests, etc. Among such TB testing procedures available, culture based tests was the largest contributor in the global TB testing market. Culture based TB tests include both solid as well as liquid culture tests that have been most widely accepted due to their relatively high specificity and accuracy than other TB tests available in the global market. However, other TB tests segment that includes IGRA, serological tests, and others is expected to register fastest growth during the forecast period from 2014 to 2020 due to many advantages such as fast result generation, high accuracy, requirement of single visit ,etc

The global tuberculosis testing market was valued at USD 1,936.1 million in 2013 and is expected to reach USD 2,619.4 million by 2020, growing at a CAGR of 4.3% from 2014 to 2020. Some of the major driving factors facilitating the growth of this market are increasing incidences of tuberculosis and the rising acceptance of new, innovative, and advanced molecular and rapid culture diagnostic tests worldwide. In addition, increased involvement of some of the world’s leading non-profit healthcare organizations for the development of new TB diagnostic tests would further boost the growth this market. Moreover, the TB diagnostics market is observed to be a propelling as many new product developers and manufacturers are expected to venture into the market with a robust pipeline of testing technologies. 

Asia Pacific dominated the global tuberculosis testing market in 2013 followed by North America. Key factor responsible for Asia Pacific dominating the global TB testing market is the presence of a vast patient pool, which is growing at a rapid pace due to very high incidence rate of the disease, especially in some of the emerging economies of the region, such as India and China. In contrast, North America has a relatively smaller patient pool with lower disease incidences. However, higher awareness, well developed healthcare infrastructure, rapid acceptance of improved but expensive TB tests and better purchasing power are contributing towards the second highest market share of North America.

Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc. QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi are some of the major players operating in the global tuberculosis testing market. Among these, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd. and Hain Lifescience GmbH are the leading players in this market aspiring to introduce novel TB testing technologies in the global market.

tuberculosis-testing-market


Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Tuberculosis Testing Market
2.2 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Tuberculosis Testing Market Overview
3.1 Introduction
     3.1.1 Epidemiology: Tuberculosis
     3.1.2 TB Incidence
     3.1.3 Diagnosis and Treatment
3.2 Market Drivers
     3.2.1 Increased Acceptance of Various TB Testing Techniques due to High Prevalence and Incidence Rates of the Disease Globally
     3.2.2 Tuberculosis Awareness and Control Programs from Government and Non-Government Organizations Worldwide Likely to Fuel Growth in Demand for Various TB Tests
     3.2.3 Rising Demand for New, Improved, and Technologically Advanced Tuberculosis Testing Procedures and Equipment
3.3 Market Restraints
     3.3.1 High Cost of Various Tuberculosis Tests may Affect the Overall Global Demand
3.4 Market Opportunities
     3.4.1 Presence of a Huge Potential Market in Most of the Emerging Nations of the World
3.5 Porter’s Five Forces Analysis: Global Tuberculosis Testing Market
     3.5.1 Bargaining Power of Suppliers
     3.5.2 Bargaining Power of Buyers
     3.5.3 Threat of Substitutes
     3.5.4 Threat of New Entrants
     3.5.5 Competitive Rivalry
3.6 Value Chain Analysis: Tuberculosis Testing Market
3.7 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography
3.8 Competitive Landscape
     3.8.1 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2013 (Value %)
     3.8.2 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players

Chapter 4 Global Tuberculosis Testing Market, by Test Type
4.1 Introduction
     4.1.1 Global Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
     4.1.2 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2013 & 2020 (Value %)
4.2 Smear Microscopy
     4.2.1 Global Smear Microscopy (TB Testing) Market Revenue, 2012 – 2020 (USD Million)
4.3 Culture Based Tests
     4.3.1 Global Culture Based Tests (TB Testing) Market Revenue, 2012 – 2020 (USD Million)
4.4 Nucleic Acid Testing
     4.4.1 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2012 – 2020 (USD Million)
4.5 Mantoux Test (Tuberculin Skin Test (TST))
     4.5.1 Global Tuberculin Skin Tests Market Revenue, 2012 – 2020 (USD Million)
4.6 Radiography (Chest X-Ray)
     4.6.1 Global Radiography (Chest X-Ray) Market Revenue, 2012 – 2020 (USD Million)
4.7 Drug Susceptibility Testing (DST)
     4.7.1 Global Drug Susceptibility Testing Market Revenue, 2012 – 2020 (USD Million)
4.8 Other Tests (Serological Tests, IGRA, etc.)
     4.8.1 Global Other TB Testing Market Revenue, 2012 – 2020 (USD Million)

Chapter 5 Global Tuberculosis Testing Market, by Geography
5.1 Overview
     5.1.1 Global Tuberculosis Testing Market Revenue, by Geography, 2012 – 2020 (USD Million)
5.2 North America
     5.2.1 North America Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
     5.2.2 North America Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
5.3 Europe
     5.3.1 Europe Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
     5.3.2 Europe Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
5.4 Asia Pacific
     5.4.1 Asia Pacific Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
     5.4.2 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
5.5 Rest of the World (RoW)
     5.5.1 RoW Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
     5.5.2 RoW Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)

Chapter 6 Recommendations
6.1 Emphasize on Price Control of Various TB Diagnostic Tests
6.2 Focus on Obtaining Increased Government Investments for the Improvement of Laboratory Capacities and Infrastructure
6.3 Target Emerging Markets of Asia Pacific and RoW

Chapter 7 Company Profiles
7.1 Abbott Laboratories
     7.1.1 Company Overview
     7.1.2 Financial Overview
     7.1.3 Product Portfolio
     7.1.4 Business Strategies
     7.1.5 Recent Developments
7.2 Akonni Biosystems, Inc.
     7.2.1 Company Overview
     7.2.2 Financial Overview
     7.2.3 Product Portfolio
     7.2.4 Business Strategies
     7.2.5 Recent Developments
7.3 Alere, Inc.
     7.3.1 Company Overview
     7.3.2 Financial Overview
     7.3.3 Product Portfolio
     7.3.4 Business Strategies
     7.3.5 Recent Developments
7.4 Becton, Dickinson and Company
     7.4.1 Company Overview
     7.4.2 Financial Overview
     7.4.3 Product Portfolio
     7.4.4 Business Strategies
     7.4.5 Recent Developments
7.5 bioMérieux SA
     7.5.1 Company Overview
     7.5.2 Financial Overview
     7.5.3 Product Portfolio
     7.5.4 Business Strategies
     7.5.5 Recent developments
7.6 Cepheid
     7.6.1 Company Overview
     7.6.2 Financial Overview
     7.6.3 Product Portfolio
     7.6.4 Business Strategies
     7.6.5 Recent Developments
7.7 Epistem Holdings Plc
     7.7.1 Company Overview
     7.7.2 Financial Overview
     7.7.3 Product Portfolio
     7.7.4 Business Strategies
     7.7.5 Recent Developments
7.8 Hain Lifescience GmbH
     7.8.1 Company Overview
     7.8.2 Financial Overview
     7.8.3 Product Portfolio
     7.8.4 Business Strategies
     7.8.5 Recent Developments
7.9 F. Hoffmann-La Roche Ltd.
     7.9.1 Company Overview
     7.9.2 Financial Overview
     7.9.3 Product Portfolio
     7.9.4 Business Strategies
     7.9.5 Recent Developments
7.10 Hologic, Inc.
     7.10.1 Company overview
     7.10.2 Financial Overview
     7.10.3 Product Portfolio
     7.10.4 Business Strategies
     7.10.5 Recent Developments
7.11 Sanofi
     7.11.1 Company Overview
     7.11.2 Financial Overview
     7.11.3 Product Portfolio
     7.11.4 Business Strategies
     7.11.5 Recent Developments
7.12 Thermo Fisher Scientific, Inc.
     7.12.1 Company Overview
     7.12.2 Financial Overview
     7.12.3 Product Portfolio
     7.12.4 Business Strategies
     7.12.5 Recent Developments
7.13 QIAGEN
     7.13.1 Company Overview
     7.13.2 Financial Overview
     7.13.3 Product portfolio
     7.13.4 Business Strategies
     7.13.5 Recent Developments

List of Figures

FIG. 1 Tuberculosis Testing: Market Segmentation
FIG. 2 Global Tuberculosis Testing Market Revenue, by Test Type, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2013 & 2020 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Tuberculosis Testing Market
FIG. 5 Value Chain Analysis: Global Tuberculosis Testing Market
FIG. 6 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography, 2013
FIG. 7 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2013 (Value %)
FIG. 8 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players
FIG. 9 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2013 & 2020 (Value %)
FIG. 10 Global Smear Microscopy (TB Testing) Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Culture Based Tests (TB Testing) Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Tuberculin Skin Tests Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Radiography (Chest X-Ray) Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global Drug Susceptibility Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Other TB Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 North America Tuberculosis Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Europe Tuberculosis Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Asia Pacific Tuberculosis Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 RoW Tuberculosis Testing Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Alere, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Becton, Dickinson and Company: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 bioMérieux SA: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Cepheid: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Epistem Holdings Plc: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Hologic, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Sanofi: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 31 QIAGEN: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Tuberculosis Testing Market
TABLE 2 Global Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 3 Global Tuberculosis Testing Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 4 North America Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 5 Europe Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 6 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)
TABLE 7 RoW Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million)


This report on tuberculosis testing studies the current as well as future prospects of the market globally. Tuberculosis (TB) is a highly contagious disease, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. People majorly suffer from two forms of TB: active tuberculosis and latent tuberculosis. The several types of TB based on the site of infection are pulmonary TB (lungs), skeletal TB (bone and joints), pleural TB, lymph node TB, gastrointestinal TB, and TB meningitis. Pulmonary TB is the most contagious disease and affects a large number of individuals globally. Based on types of tests, the tuberculosis testing market has been segmented into seven major categories: smear microscopy, culture-based tests, nucleic acid testing, Mantoux test or tuberculin skin tests (TST), radiography (chest x-ray), drug susceptibility testing (DST) and other TB tests.

This report comprises an elaborate executive summary that includes a market snapshot that provides overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global tuberculosis testing market with respect to leading market segments based on types of tests as well as different geographic regions. The respective markets for the considered tuberculosis tests have been extensively analyzed on the basis of their usefulness, effectiveness, sales revenue and geographic presence. The market size and forecast in terms of USD million for each type of test has been provided for the period from 2012 to 2020. This report on tuberculosis testing market also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.

Geographically, the global tuberculosis testing market has been categorized into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The four major geographic markets have been further divided into seven sub-segments (major TB tests). The market size and forecast for each of these sub-segments have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The study also incorporates the competitive scenario in these regions. 

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global tuberculosis testing market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter’s five forces analysis and key players’ market share and product wise heat map analysis in 2013 for the global TB testing market. 

A list of recommendations has been provided for new entrants as well as existing market players to help establish a strong presence in the market and increase their market share. The report also profiles major players in the tuberculosis testing market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic, QIAGEN, Sanofi and Thermo Fisher Scientific, Inc.
The global tuberculosis testing market is segmented as follows:

Tuberculosis Testing Market, by Test Type
  • Smear Microscopy
  • Culture Based Tests
  • Nucleic Acid Testing
  • Mantoux Test (Tuberculin Skin Test)
  • Radiography (Chest X-Ray)
  • Drug Susceptibility Testing (DST)
  • Other Tests (Serological Tests, IGRA, ADA, etc.)
Tuberculosis Testing Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


 
 
Back To Top